Abstract Oral Presentation Session IV
论文报告第四场

1:30 PM-3:00 PM Thursday, March 30, 2017

2017年03月30日 星期四   1:30 PM-3:00 PM

Room 306AB, Level 3

三层306AB会议室

  
Moderator 主持人 Wei Gao 高炜, Shuyang Zhang 张抒扬, Jianhua Zhu 朱建华, Jinqing Yuan 袁晋青

1:30 PM-

AS-0142: Abluminal Groove-Filled Biodegradable Polymer Sirolimus-Eluting Stent vs. Cobalt-Chromium Everolimus-Eluting Stent in De Novo Native Coronary Lesions: The Final 5-Year Results of the TARGET I Randomized Controlled Trial
AS-0142:新型单面刻槽生物可降解聚合物涂层雷帕霉素洗脱支架治疗冠脉原位病变的长期疗效和安全性
Chongjian Li 李崇剑

1:40 PM-

Q&A
讨论

1:45 PM-

AS-0147: Association of Body Mass Index with Mortality in Chinese Patients after Percutaneous Coronary Intervention: A Large Single Center Data
AS-0147:体重指数与行经皮冠状动脉介入治疗患者死亡率的相关性 - 单中心研究
Huanhuan Wang 王欢欢

1:55 PM-

Q&A
讨论

2:00 PM-

AS-0149: A Randomized Comparison of Novel Biodegradable Polymer- and Durable Polymer-Coated Cobalt-Chromium Sirolimus-Eluting Stents: Three-Year Outcomes of the I-LOVE-IT 2 Trial
AS-0149:新型生物可降解涂层支架与永久涂层钴铬合金西罗莫司药物洗脱支架的随机对照研究:I-LOVE-IT2三年结果
Lei Song 宋雷

2:10 PM-

Q&A
讨论

2:15 PM-

AS-0150: One-Year Prognostic Utility of the SYNTAX Score II in Complex PCI with Biodegradable Polymer Drug-Eluting Stents: A PANDA-II Analysis
AS-0150:对涂层可降解支架治疗复杂冠脉介入治疗术后1年结果对预测价值:PANDA-III亚组分析
Changdong Guan 管常东

2:25 PM-

Q&A
讨论

2:30 PM-

AS- 0151: Safety and Efficacy of a Novel Abluminal Groove-Filled Biodegradable Polymer Sirolimus-Eluting Stent for the Treatment of De Novo Coronary Lesions: Four-Year Results of the Patient-Level Pooled Analysis from TARGET I and TARGET II Trials
AS- 0151:新型单边刻槽涂层可降解雷帕霉素药物洗脱支架系统治疗原发冠脉病变对安全性、有效性:TARGET I 和TARGET II研究患者水平荟萃分析4年结果
Changdong Guan 管常东

2:40 PM-

Q&A
讨论

2:45 PM-

AS-0186: Impact of Gender Difference in Clinical Presentation on Long-Term Outcomes in Chinese Patients Undergoing Percutaneous Coronary Intervention
AS-0186:性别差异对不同临床表型经皮冠状动脉介入治疗的冠心病患者远期预后的影响
Xiaofang Tang 唐晓芳

2:55 PM-

Q&A
讨论

3:00 PM-

Adjourn
休会